655 related articles for article (PubMed ID: 20172840)
1. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.
Liu Y; Wu F
Environ Health Perspect; 2010 Jun; 118(6):818-24. PubMed ID: 20172840
[TBL] [Abstract][Full Text] [Related]
2. Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis.
Liu Y; Chang CC; Marsh GM; Wu F
Eur J Cancer; 2012 Sep; 48(14):2125-36. PubMed ID: 22405700
[TBL] [Abstract][Full Text] [Related]
3. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.
Wogan GN; Kensler TW; Groopman JD
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(2):249-57. PubMed ID: 21623489
[TBL] [Abstract][Full Text] [Related]
4. Aflatoxins, hepatocellular carcinoma and public health.
Magnussen A; Parsi MA
World J Gastroenterol; 2013 Mar; 19(10):1508-12. PubMed ID: 23539499
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: from gene to public health.
Montesano R; Hainaut P; Wild CP
J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
[TBL] [Abstract][Full Text] [Related]
6. Application of Probabilistic Modeling to Quantify the Reduction Levels of Hepatocellular Carcinoma Risk Attributable to Chronic Aflatoxins Exposure.
Wambui JM; Karuri EG; Ojiambo JA; Njage PM
Nutr Cancer; 2017 Jan; 69(1):1-13. PubMed ID: 27918845
[TBL] [Abstract][Full Text] [Related]
7. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
[TBL] [Abstract][Full Text] [Related]
8. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China.
Chen JG; Egner PA; Ng D; Jacobson LP; Muñoz A; Zhu YR; Qian GS; Wu F; Yuan JM; Groopman JD; Kensler TW
Cancer Prev Res (Phila); 2013 Oct; 6(10):1038-45. PubMed ID: 23963804
[TBL] [Abstract][Full Text] [Related]
9. Aflatoxins as a cause of hepatocellular carcinoma.
Kew MC
J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
[TBL] [Abstract][Full Text] [Related]
10. Global risk assessment of aflatoxins in maize and peanuts: are regulatory standards adequately protective?
Wu F; Stacy SL; Kensler TW
Toxicol Sci; 2013 Sep; 135(1):251-9. PubMed ID: 23761295
[TBL] [Abstract][Full Text] [Related]
11. Aflatoxin exposure in viral hepatitis patients in Turkey.
Mizrak D; Engin B; Onder FO; Yener B; Bektaş M; Biyikli Z; Idilman R; Cinar K; Karayalçin K; Ersöz S; Karayalçin S; Ozden A; Yurdaydin C; Yazihan N; Ataoğlu H; Bozkaya H; Uzunalimoğlu O
Turk J Gastroenterol; 2009 Sep; 20(3):192-7. PubMed ID: 19821201
[TBL] [Abstract][Full Text] [Related]
12. Global geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwide.
Palliyaguru DL; Wu F
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2013; 30(3):534-40. PubMed ID: 23281740
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenic crops: Analyzing the effect of aflatoxin on global liver cancer rates.
Tillett T
Environ Health Perspect; 2010 Jun; 118(6):A258. PubMed ID: 20515711
[No Abstract] [Full Text] [Related]
15. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
16. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
[TBL] [Abstract][Full Text] [Related]
17. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
18. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.
Chuang SC; La Vecchia C; Boffetta P
Cancer Lett; 2009 Dec; 286(1):9-14. PubMed ID: 19091458
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.
McCullough AK; Lloyd RS
DNA Repair (Amst); 2019 May; 77():76-86. PubMed ID: 30897375
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment for aflatoxin: II. Implications of human epidemiology data.
Bruce RD
Risk Anal; 1990 Dec; 10(4):561-9. PubMed ID: 2287783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
